Extended dual antiplatelet therapy after acute myocardial infarction. Current evidence and future perspectives

Submitted: February 12, 2019
Accepted: May 6, 2019
Published: July 4, 2019
Abstract Views: 1426
PDF: 853
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Patients with acute myocardial infarction (AMI) are at increased risk of recurrent ischemic events after hospital discharge, despite optimal medical therapy. Current practice guidelines strongly encourage the early assessment of the residual ischemic risk in post-AMI patients, in order to identify those who may benefit from a prolonged dual antiplatelet therapy. To this end, some scoring systems have been proposed. However, most scores were developed for patients with stable coronary artery disease undergoing percutaneous coronary intervention. Moreover, nearly all failed to be implemented in everyday clinical practice, probably because of the perceived complexity due to the large number of incorporated variables. Therefore, the identification of the ideal AMI patient who can benefit from a prolonged (beyond 1 year after the index event) dual antiplatelet therapy remains to be clarified, especially when the bleeding risk associated with such therapy is considered. In this review, we summarize the current evidence on the prolonged use of dual antiplatelet therapy after AMI, with a special focus on recent advances regarding the identification of high-risk patients who may derive a favorable net clinical benefit from such a therapeutic strategy.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

How to Cite

Cosentino, Nicola, Jeness Campodonico, Valentina Milazzo, Katia Celentano, Marco Moltrasio, Pompilio Faggiano, and Giancarlo Marenzi. 2019. “Extended Dual Antiplatelet Therapy After Acute Myocardial Infarction. Current Evidence and Future Perspectives”. Monaldi Archives for Chest Disease 89 (2). https://doi.org/10.4081/monaldi.2019.1046.